Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models

Antiviral Research

Volumn 66, Issue 2-3, 2005, Pages 99-102

  Paragas, Jason ^a   Blatt, Lawrence M ^b   Hartmann, Chris ^a   Huggins, John W ^a   Endy, Tim P ^a,c  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b InterMune Inc   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Alfacon1; Antiviral; Interferon; SARS corona; Therapy

Indexed keywords

CONSENSUS INTERFERON;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; IC 50; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SARS CORONAVIRUS; STATISTICAL SIGNIFICANCE;

ANTIVIRAL AGENTS; CYTOPATHOGENIC EFFECT, VIRAL; HUMANS; INTERFERON TYPE I, RECOMBINANT; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; SARS VIRUS;

ANIMALIA; CORONA VIRUS; SARS CORONAVIRUS; SARS COV;

EID: 19344366500     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.01.002     Document Type: Article

References (26)

1. C.F. Basler, and A. Garcia-Sastre Viruses and the type I interferon antiviral system: induction and evasion Int. Rev. Immunol. 21 2002 305 337
2. L.M. Blatt, J.M. Davis, S.B. Klein, and M.W. Taylor The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon J. Interferon Cytokine Res. 16 1996 489 499
3. C.M. Booth, L.M. Matukas, G.A. Tomlinson, A.R. Rachlis, D.B. Rose, H.A. Dwosh, S.L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, I.E. Ephtimios, I. Kitai, B.D. Mederski, S.B. Shadowitz, W.L. Gold, L.A. Hawryluck, E. Rea, J.S. Chenkin, D.W. Cescon, S.M. Poutanen, and A.S. Detsky Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area J. Am. Med. Assoc. 289 2003 2801 2809
4. F. Chen, K.H. Chan, Y. Jiang, R.Y. Kao, H.T. Lu, K.W. Fan, V.C. Cheng, W.H. Tsui, I.F. Hung, T.S. Lee, Y. Guan, J.S. Peiris, and K.Y. Yuen In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds J. Clin. Virol. 31 2004 69 75
5. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H.W. Doerr Treatment of SARS with human interferons Lancet 362 2003 293 294
6. J. Cinatl Jr., M. Michaelis, M. Scholz, and H.W. Doerr Role of interferons in the treatment of severe acute respiratory syndrome Expert Opin. Biol. Ther. 4 2004 827 836
7. M. Enserink SARS treatment. Interferon shows promise in monkeys Science 303 2004 1273 1275
8. R.A. Fouchier, T. Kuiken, M. Schutten, G. Van Amerongen, G.J. Van Doornum, B.G. Van Den Hoogen, M. Peiris, W. Lim, K. Stohr, and A.D. Osterhaus Aetiology: Koch's postulates fulfilled for SARS virus Nature 423 2003 240
9. B.L. Haagmans, T. Kuiken, B.E. Martina, R.A. Fouchier, G.F. Rimmelzwaan, G. Van Amerongen, D. Van Riel, T. De Jong, S. Itamura, K.H. Chan, M. Tashiro, and A.D. Osterhaus Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques Nat. Med. 10 2004 290 293
10. L.E. Hensley, L.E. Fritz, P.B. Jahrling, C.L. Karp, J.W. Huggins, and T.W. Geisbert Interferon-beta 1a and SARS coronavirus replication Emerg. Infect. Dis. 10 2004 317 319
11. K.V. Holmes SARS-associated coronavirus N. Engl. J. Med. 348 2003 1948 1951
12. J. Imanishi, S. Hoshino, A. Hoshino, T. Oku, M. Kita, and T. Kishida New simple dye-uptake assay for interferon Biken J. 24 1981 103 108
13. H. Ishitsuka, Y. Nomura, and K. Takano A simple and efficient microassay method for titration of interferon Microbiol. Immunol. 21 1977 583 591
14. I. Julkunen, K. Linnavuori, and T. Hovi Sensitive interferon assay based on immunoenzymatic quantification of viral antigen synthesis J. Virol. Methods 5 1982 85 91
15. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell, A.E. Ling, C.D. Humphrey, W.J. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. Derisi, J.Y. Yang, N. Cox, J.M. Hughes, J.W. Leduc, W.J. Bellini, and L.J. Anderson A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 2003 1953 1966
16. D.E. Levy, and A. Garcia-Sastre The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion Cytokine Growth Factor Rev. 12 2001 143 156
17. M.R. Loutfy, L.M. Blatt, K.A. Siminovitch, S. Ward, B. Wolff, H. Lho, D.H. Pham, H. Deif, E.A. Lamere, M. Chang, K.C. Kain, G.A. Farcas, P. Ferguson, M. Latchford, G. Levy, J.W. Dennis, E.K. Lai, and E.N. Fish Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study J. Am. Med. Assoc. 290 2003 3222 3228
18. M.A. Marra, S.J. Jones, C.R. Astell, R.A. Holt, A. Brooks-Wilson, Y.S. Butterfield, J. Khattra, J.K. Asano, S.A. Barber, S.Y. Chan, A. Cloutier, S.M. Coughlin, D. Freeman, N. Girn, O.L. Griffith, S.R. Leach, M. Mayo, H. McDonald, S.B. Montgomery, P.K. Pandoh, A.S. Petrescu, A.G. Robertson, J.E. Schein, A. Siddiqui, D.E. Smailus, J.M. Stott, G.S. Yang, F. Plummer, A. Andonov, H. Artsob, N. Bastien, K. Bernard, T.F. Booth, D. Bowness, M. Czub, M. Drebot, L. Fernando, R. Flick, M. Garbutt, M. Gray, A. Grolla, S. Jones, H. Feldmann, A. Meyers, A. Kabani, Y. Li, S. Normand, U. Stroher, G.A. Tipples, S. Tyler, R. Vogrig, D. Ward, B. Watson, R.C. Brunham, M. Krajden, M. Petric, D.M. Skowronski, C. Upton, and R.L. Roper The Genome sequence of the SARS-associated coronavirus Science 300 2003 1399 1404
19. H. Moriguchi, and C. Sato Treatment of SARS with human interferons Lancet 362 2003 1159
20. M.L. Ng, S.H. Tan, E.E. See, E.E. Ooi, and A.E. Ling Proliferative growth of SARS coronavirus in Vero E6 cells J. Gen. Virol. 84 2003 3291 3303
21. O.N. Ozes, Z. Reiter, S. Klein, L.M. Blatt, and M.W. Taylor A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities J. Interferon Res. 12 1992 55 59
22. J.S. Peiris, S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, W. Lim, J. Nicholls, W.K. Yee, W.W. Yan, M.T. Cheung, V.C. Cheng, K.H. Chan, D.N. Tsang, R.W. Yung, T.K. Ng, and K.Y. Yuen Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 2003 1319 1325
23. S.J. Sperber, and F.G. Hayden Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta J. Interferon Res. 9 1989 285 293
24. U. Stroher, A. Dicaro, Y. Li, J.E. Strong, F. Aoki, F. Plummer, S.M. Jones, and H. Feldmann Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha J. Infect Dis. 189 2004 1164 1167
25. H. Suzuki, and T. Tango A multicenter, randomized, controlled clinical trial of interferon alfacon-1 in comparison with lymphoblastoid interferon-alpha in patients with high-titer chronic hepatitis C virus infection Hepatol. Res. 22 2002 1 12
26. M.J. Tong, K.R. Reddy, W.M. Lee, P.J. Pockros, J.C. Hoefs, E.B. Keeffe, F.B. Hollinger, E.J. Hathcote, H. White, R.T. Foust, D.M. Jensen, E.L. Krawitt, H. Fromm, M. Black, L.M. Blatt, M. Klein, and J. Lubina Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group Hepatology 26 1997 747 754